Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... contracts from the Department of Defense for development of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via the ... held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, ...
2009 NOV 16 ... tumour type and may also be of potential utility in the development of vaccines against hepatitis, HIV and other chronic infectious diseases. Keywords: AIDS, Acquired ...
2009 NOV 9 ... published in the Journal of General Virology, "Understanding the origin and nature of hepatitis C virus (HCV) genetic diversity is critical for improving treatment and vaccine design, ... Epidemiology, Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Infectious Disease, Vaccines, Virology, University of Oxford. This article was prepared by Hepatitis ...
2009 NOV 16 ... will provide valuable perspective as Dynavax advances its plans for its Phase 3 hepatitis B vaccine and pipeline products." Dr. Cano is President and Founder of ... Directors effective November 3, 2009. "A recognized scientific leader in vaccines and infectious diseases, Francis brings unique expertise and broad experience in ...
2009 NOV 9 ... (Nasdaq: DVAX) announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients. These data will be presented in a poster ... HBV, Hepatitis B Virus, Hepatology, Infectious Disease, Kidney Disease, Vaccines, Virology, Dynavax Technologies Corporation. This article was prepared by ...
2009 NOV 16 ... of drug candidates targeted to Toll-like receptors for potential applications in chronic hepatitis C virus infection and autoimmune diseases, and to support our partnered programs in ... Financial, Investing, Autoimmune Diseases, Autoimmune Disorder, Biotechnology, Cancer Vaccines, Chronic Hepatitis C, Clinical Trial Research, Clinical Trials, Drug Development, ...
2009 NOV 9 ... session from 8:00 am - 1:00 pm on Tuesday, November 3rd, 2009. About HCV and Protides Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV). It is estimated that ... MSCRAMM® protein technology to Wyeth for the development of staphylococcal vaccines. Keywords: , Health, Biotechnology, Clinical Trials, Hospitals, Infectious ...
2009 NOV 28 ... of shingles-related symptoms, including acute pain and PHN. About HCV and Protides Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV). It is estimated that ... MSCRAMM® protein technology to Wyeth for the development of staphylococcal vaccines.Keywords: Health, Biotechnology, Clinical Trials, Infectious Diseases, ...
2009 NOV 23 ... to develop novel adjuvants to support the development of an effective vaccine against hepatitis C virus." Dr. Gale's laboratory has been instrumental in defining the ... look forward to delivering into the clinical pipeline new agents to boost the power of vaccines to improve human health," said Dr. Iadonato. Dr. Gale concurred, "More ...
2009 NOV 23 ... repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. To receive future updates, via email including quarterly ... 4, 2009 (see link below) http://www.marketwatch.com/story/novartis-to-buy-85-of-chinese-vaccines-producer-2009-11-04?siteid=yhoof2. HTDS management, elected not to release ...
2009 NOV 23 ... Data detailed in 'Towards a small animal model for hepatitis C' have been presented. "Hepatitis C virus (HCV) causes chronic liver disease and ... Immunization, Infectious Disease, Interferon, Pre-Trials Research, Treatment, Vaccines, Viral Inhibition, Viral Therapy, Virology. This article was prepared by ...
2009 NOV 9 ... Calmette-Guerin (BCG), diphtheria-tetanus-pertussis (DTP3), poliomyelitis (polio3), hepatitis B (HepB3), and measles] in multiple logistic regressions, controlling for household ... associated with lower adjusted odds ratios (AOR) of child vaccination for all vaccines [(AOR) 0.60-0.74, all p<or=0.036] except measles (0.75, p=0.073), distance to mobile ...
2009 NOV 2 ... polio (IPV), one measles, mumps and rubella (MMR), three H influenza type B (HiB), three hepatitis B, one chicken pox (VZV) and four pneumococcal conjugate vaccines. National ...
2009 NOV 16 ... the measles-mumps-rubella vaccine (MMRV), pneumococcal conjugate vaccine (PCV7), and a Hepatitis A (HepA) vaccine at 12 months of age. In the control group, 12-month-olds received only ... Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), presented Safety of a ...
2009 NOV 2 ... "Communal living situations such as nursing homes create a risk for the spread of hepatitis B virus and hepatitis C virus (HCV). The aim of this Study was to determine the ... not received hepatitis B vaccination indicates the need for administering hepatitis B vaccines in this group." Maral and colleagues published their study in the Journal ...
2009 NOV 23 ... According to a study from Taipei, Taiwan, "Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma. This ... USA. Keywords: City:Taipei, Country:Taiwan, Antigens, Biotechnology, Cancer Vaccines, Gastroenterology, HBV Vaccines, Hepatitis B Virus, Hepatocellular Cancer, ...
2009 NOV 23 ... to a study from Havana, Cuba, "CIGB-230, a mixture of a DNA plasmid expressing hepatitis C virus (HCV) structural antigens and a HCV recombinant capsid protein, has demonstrated ... Keywords: City:Havana, Country:Cuba, Biotechnology, DNA Research, DNA Vaccines, Drug Development, Gastroenterology, HCV, Hepatitis C Virus, Hepatology, Immunization, ...
2009 NOV 9 ... other vaccines recommended to be given at an earlier age: measles- mumps-rubella (MMR), hepatitis B and varicella (chickenpox) vaccine. Influenza vaccine is also recommended every year ...
